title: The soluble leptin receptor in olanzapine-induced weight gain: results from a prospective study.
authors.forename: Christoph
authors.initials: C
authors.lastname: Ebenbichler
authors.forename: Markus
authors.initials: M
authors.lastname: Laimer
authors.forename: Michael
authors.initials: M
authors.lastname: Kranebitter
authors.forename: Monika
authors.initials: M
authors.lastname: Lechleitner
authors.forename: Josef R
authors.initials: JR
authors.lastname: Patsch
authors.forename: Susanne
authors.initials: S
authors.lastname: Baumgartner
authors.forename: Monika
authors.initials: M
authors.lastname: Edlinger
authors.forename: Alex
authors.initials: A
authors.lastname: Hofer
authors.forename: Martina
authors.initials: M
authors.lastname: Hummer
authors.forename: Maria A
authors.initials: MA
authors.lastname: Rettenbacher
authors.forename: W Wolfgang
authors.initials: WW
authors.lastname: Fleischhacker
mesh_terms: D014150:Antipsychotic Agents / Q000009:adverse effects*; D001569:Benzodiazepines / Q000009:adverse effects*; D016022:Case-Control Studies; D006801:Humans; D000077152:Olanzapine; D011956:Receptors, Cell Surface / Q000097:blood / Q000187:drug effects*; D054411:Receptors, Leptin; D012559:Schizophrenia / Q000188:drug therapy*; D015430:Weight Gain
chemical_list: D014150:Antipsychotic Agents; C515448:LEPR protein, human; D011956:Receptors, Cell Surface; D054411:Receptors, Leptin; D001569:Benzodiazepines; D000077152:Olanzapine